MAPT and Alzheimer disease: Moreover, an evaluation of the diagnostic value of netrin-1 as combined with amyloid pathology/neurodegeneration blood biomarkers (e.g., Aβ, Tau and phosphorylated Tau) and amyloid-PET findings would provide further pertinent information regarding their use and validity as AD markers.